Characterization of high mobility group protein binding to cisplatin-damaged DNA

Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4

1970 • 253,849 citations

Tissue sulfhydryl groups

1959 • 25,130 citations

GLUTATHIONE

1983 • 5,487 citations

Redox Regulation of Fos and Jun DNA-Binding Activity in Vitro

1990 • 1,592 citations

Biochemistry of the SH group

1972 • 714 citations

Treatment of testicular cancer: a new and improved model.

1990 • 517 citations

Specific Binding of Chromosomal Protein HMG1 to DNA Damaged by the Anticancer Drug Cisplatin

1992 • 492 citations

Reevaluation of interaction of cis-dichloro(ethylenediamine)platinum(II) with DNA

1986 • 450 citations

Combined treatment of radiation and cisdiamminedichloroplatinum (II): a review of experimental and clinical data

1987 • 358 citations

Molecular mechanisms of drug resistance

1990 • 279 citations

Nonhistone Proteins HMG ₁ and HMG ₂ Change the DNA Helical Structure

1978 • 243 citations

Hormone Receptors

1979 • 197 citations

An improved large scale fractionation of high mobility group non-histone chromatin proteins

1975 • 171 citations

[36] Reactions with N-ethylmaleimide and p-mercuribenzoate

1972 • 161 citations

Purification of nuclear proteins that bind to cisplatin-damaged DNA. Identity with high mobility group proteins 1 and 2.

1992 • 150 citations

Inhibition of the BamHI cleavage and unwinding of pBR322 deoxyribonucleic acid by the antitumor drug cis-dichlorodiammineplatinum(II)

1981 • 138 citations

Characterization of a DNA damage-recognition protein from mammalian cells that binds specifically to intrastrand d(GpG) and d(ApG) DNA adducts of the anticancer drug cisplatin

1990 • 133 citations

High mobility group proteins 1 and 2 function as general class II transcription factors

1990 • 129 citations

Nonhistone proteins HMG₁and HMG₂unwind DNA double helix

1979 • 99 citations

Primary structure of non-histone protein HMG1 revealed by the nucleotide sequence

1988 • 98 citations

Advances in Internal Medicine.

1979 • 90 citations

Therapeutic implications of tumor heterogeneity.

1989 • 83 citations

Cisplatin in advanced cancer of the cervix: an update.

1991 • 83 citations

Studies on the degradation of high mobility group non-histone chromosomal proteins

1978 • 71 citations

New platinum complexes in clinical trials

1983 • 62 citations

Primary structure of non-histone chromosomal protein HMG2 revealed by the nucleotide sequence

1990 • 56 citations

Identification of inducible damage-recognition proteins that are overexpressed in HeLa cells resistant to cis-diamminedichloroplatinum (II)

1991 • 56 citations

Experience with cisplatin in treatment regimens for esophageal cancer.

1991 • 49 citations

Structure of a gene coding for human HMG2 protein.

1992 • 35 citations

Resistance patterns between cis-diamminedichloroplatinum(II) and ionizing radiation.

1991 • 34 citations

Cis-diamminedichloroplatinum(II) selectively cross-links high mobility group proteins 1 and 2 to DNA in micrococcal nuclease accessible regions of chromatin

1987 • 33 citations

The role of cisplatin in treatment regimens for squamous cell carcinoma of the head and neck.

1991 • 29 citations

Cytotoxic chemotherapy for advanced bladder cancer: cisplatin-containing regimens.

1991 • 17 citations

The integration of platinum and radiotherapy in the treatment of lung cancer.

1991 • 4 citations